These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 22219336)

  • 1. Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics.
    Hering NA; Fromm M; Schulzke JD
    J Physiol; 2012 Mar; 590(5):1035-44. PubMed ID: 22219336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
    Hering NA; Schulzke JD
    Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial tight junctions in intestinal inflammation.
    Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
    Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function.
    Grosheva I; Zheng D; Levy M; Polansky O; Lichtenstein A; Golani O; Dori-Bachash M; Moresi C; Shapiro H; Del Mare-Roumani S; Valdes-Mas R; He Y; Karbi H; Chen M; Harmelin A; Straussman R; Yissachar N; Elinav E; Geiger B
    Gastroenterology; 2020 Nov; 159(5):1807-1823. PubMed ID: 32653496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease and the apical junctional complex.
    Bruewer M; Samarin S; Nusrat A
    Ann N Y Acad Sci; 2006 Aug; 1072():242-52. PubMed ID: 17057204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-Lessons from experimental models and patients.
    Schlegel N; Boerner K; Waschke J
    Acta Physiol (Oxf); 2021 Jan; 231(1):e13492. PubMed ID: 32419327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tight junction in inflammatory disease: communication breakdown.
    Edelblum KL; Turner JR
    Curr Opin Pharmacol; 2009 Dec; 9(6):715-20. PubMed ID: 19632896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
    Mankertz J; Schulzke JD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy and tight junction proteins in the intestine and intestinal diseases.
    Hu CA; Hou Y; Yi D; Qiu Y; Wu G; Kong X; Yin Y
    Anim Nutr; 2015 Sep; 1(3):123-127. PubMed ID: 29767173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens.
    Velikova T; Kyurkchiev D; Spassova Z; Karakolev I; Ivanova-Todorova E; Altankova I; Stanilova S
    Cytokine; 2017 Apr; 92():12-19. PubMed ID: 28088612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases.
    Sugita K; Kabashima K
    J Leukoc Biol; 2020 May; 107(5):749-762. PubMed ID: 32108379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red wine extract preserves tight junctions in intestinal epithelial cells under inflammatory conditions: implications for intestinal inflammation.
    Nunes C; Freitas V; Almeida L; Laranjinha J
    Food Funct; 2019 Mar; 10(3):1364-1374. PubMed ID: 30735221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of cytokine modulation of epithelial tight junction barrier.
    Al-Sadi R; Boivin M; Ma T
    Front Biosci (Landmark Ed); 2009 Jan; 14(7):2765-78. PubMed ID: 19273235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic colitis-induced visceral pain is associated with increased anxiety during quiescent phase.
    Salameh E; Meleine M; Gourcerol G; do Rego JC; do Rego JL; Legrand R; Breton J; Aziz M; Guérin C; Coëffier M; Savoye G; Marion-Letellier R
    Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G692-G700. PubMed ID: 30735453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of IBD associated diarrhea.
    Anbazhagan AN; Priyamvada S; Alrefai WA; Dudeja PK
    Tissue Barriers; 2018; 6(2):e1463897. PubMed ID: 29737913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.
    Martini E; Krug SM; Siegmund B; Neurath MF; Becker C
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):33-46. PubMed ID: 28560287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut inflammation: current update on pathophysiology, molecular mechanism and pharmacological treatment modalities.
    Gyires K; Tóth ÉV; Zádori SZ
    Curr Pharm Des; 2014; 20(7):1063-81. PubMed ID: 23782146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of disrupted intestinal barrier in inflammatory bowel diseases.
    Salim SY; Söderholm JD
    Inflamm Bowel Dis; 2011 Jan; 17(1):362-81. PubMed ID: 20725949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.